Reducing Senescent Cell Burden in Aging and Disease

衰老 疾病 表型 DNA损伤 机制(生物学) 老化 医学 基因组不稳定性 染色质 生物 癌症研究 生物信息学 内科学 遗传学 DNA 基因 哲学 认识论
作者
Robert J. Pignolo,João F. Passos,Sundeep Khosla,Tamar Tchkonia,James L. Kirkland
出处
期刊:Trends in Molecular Medicine [Elsevier BV]
卷期号:26 (7): 630-638 被引量:175
标识
DOI:10.1016/j.molmed.2020.03.005
摘要

Accumulation of senescent cells is a fundamental aging process that contributes to age-onset disease, compromises health-span, and shortens life-span. Senescent cells have been cleared genetically in animal models and pharmacologically in animals and humans. Reduction in senescent cell burden can be accomplished pharmacologically by targeting antiapoptotic networks or SASP. Early, proof-of-principle pilot clinical studies on senolytic agents are addressing safety and target engagement. Cellular senescence is a primary aging process and tumor suppressive mechanism characterized by irreversible growth arrest, apoptosis resistance, production of a senescence-associated secretory phenotype (SASP), mitochondrial dysfunction, and alterations in DNA and chromatin. In preclinical aging models, accumulation of senescent cells is associated with multiple chronic diseases and disorders, geriatric syndromes, multimorbidity, and accelerated aging phenotypes. In animals, genetic and pharmacologic reduction of senescent cell burden results in the prevention, delay, and/or alleviation of a variety of aging-related diseases and sequelae. Early clinical trials have thus far focused on safety and target engagement of senolytic agents that clear senescent cells. We hypothesize that these pharmacologic interventions may have transformative effects on geriatric medicine. Cellular senescence is a primary aging process and tumor suppressive mechanism characterized by irreversible growth arrest, apoptosis resistance, production of a senescence-associated secretory phenotype (SASP), mitochondrial dysfunction, and alterations in DNA and chromatin. In preclinical aging models, accumulation of senescent cells is associated with multiple chronic diseases and disorders, geriatric syndromes, multimorbidity, and accelerated aging phenotypes. In animals, genetic and pharmacologic reduction of senescent cell burden results in the prevention, delay, and/or alleviation of a variety of aging-related diseases and sequelae. Early clinical trials have thus far focused on safety and target engagement of senolytic agents that clear senescent cells. We hypothesize that these pharmacologic interventions may have transformative effects on geriatric medicine. programed cell death during normal growth, development, and removal of potentially harmful cells, such as those that are precancerous or virus-infected. process by which cells undergo irreversible growth arrest, usually secondary to toxic insults or unchecked mitogenic signals. Senescent cells are characterized by several dramatic changes, including epigenetic remodeling of chromatin, changes in the abundance and functionality of organelles, and the enhanced secretion of proinflammatory molecules; however, many of these alterations are not universal and will depend on the cell type and type of inducing stimuli. reduction in the lifetime burden of illness when onset of chronic disease is postponed to a greater extent than the increase in life expectancy. repertoire of molecules released from damaged or necrotic cells that activate the innate immune system by binding to pattern recognition receptors. They promote pathological inflammatory responses and induce cellular senescence. proposition that since aging underlies most chronic disease and debilitating states, interventions that retard primary aging processes would also concomitantly prevent, delay, or alleviate multiple age-related conditions. in mammals, the principal regulatory mechanism for a wide array of cytokines and growth factors. The JAK pathway is more highly active in senescent cells and its inhibition can suppress the SASP. resembling the aging phenotype in older individuals, usually in reference to premature or accelerated aging. p16 is an inhibitor of cyclin-dependent kinases (CDKs) that prevents CDK4/6-binding of cyclin D and formation of an active protein complex that phosphorylates retinoblastoma protein (pRB). If Rb is phosphorylated by CDKs, it dissociates from E2F family transcription factors (E2F 1–3), enters the nucleus, and promotes transcription of target genes necessary for G1 to S phase cell cycle transition. For clarity, we have simplified this pathway, however, it should be noted that other players may be involved, including several non-E2F target genes of Rb. p16 hypermethylation, mutation, or deletion leads to dysregulation of cell cycle progression. Increased expression of p16 is associated with cell senescence. p53-dependent cell cycle arrest is the primary response to DNA damage. p21, an inhibitor of cyclin-dependent kinases, is the primary mediator of downstream cell cycle arrest due to p53 activation. The p21 protein functions as a regulator of cell cycle progression at both G1 and S phases. Activation of p21 is associated with cell senescence. region of repetitive nucleotide sequences at chromosome ends; associated with a protein complex to form a protective loop structure that prevents against deterioration or fusion with adjacent chromosomes. With replication cycles telomeres grow shorter or dysfunctional and when critically short or dysfunctional are associated with a DNA damage response that triggers cellular senescence. elements within DNA that can be translated into RNA, be reverse-transcribed into DNA, and re-inserted at new sites in chromosomes (‘jumping genes’). Transposons can disrupt chromosomal structure and elicit responses within cells that contribute to inflammation and the SASP.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
虚幻百招发布了新的文献求助10
刚刚
刚刚
真烦人完成签到,获得积分10
刚刚
yowgo完成签到,获得积分10
1秒前
2秒前
不安的米老鼠完成签到,获得积分10
2秒前
2秒前
上官若男的应助被君莫笑采纳,获得10
3秒前
虚幻百招发布了新的文献求助10
3秒前
科研通AI65的应助被科研通管家采纳,获得10
3秒前
liuliu发布了新的文献求助10
3秒前
molihuakai的应助被科研通管家采纳,获得10
3秒前
虚幻百招发布了新的文献求助10
3秒前
常富育发布了新的文献求助10
3秒前
Hello的应助被科研通管家采纳,获得10
3秒前
虚幻百招发布了新的文献求助10
3秒前
虚幻百招发布了新的文献求助10
3秒前
CarryLJR的应助被科研通管家采纳,获得10
3秒前
酷波er的应助被科研通管家采纳,获得10
4秒前
香蕉觅云的应助被开心德地采纳,获得10
4秒前
隐形曼青的应助被科研通管家采纳,获得10
4秒前
4秒前
4秒前
4秒前
4秒前
CodeCraft的应助被科研通管家采纳,获得10
4秒前
羊正发布了新的文献求助10
4秒前
英姑的应助被科研通管家采纳,获得10
4秒前
充电宝的应助被科研通管家采纳,获得10
4秒前
5秒前
无花果的应助被科研通管家采纳,获得10
5秒前
SciGPT的应助被科研通管家采纳,获得10
5秒前
汉堡包的应助被科研通管家采纳,获得10
5秒前
Sia完成签到,获得积分10
5秒前
5秒前
桐桐的应助被pride采纳,获得10
6秒前
Jerry发布了新的文献求助10
7秒前
朋友发布了新的文献求助10
8秒前
Sia发布了新的文献求助10
8秒前
充电宝的应助被我我我采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189137
求助须知:如何正确求助?哪些是违规求助? 9576601
关于积分的说明 21848766
捐赠科研通 7787145
什么是DOI,文献DOI怎么找? 3435490
关于科研通互助平台的介绍 2559732
邀请新用户注册赠送积分活动 2482462